Greenwood Gearhart’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
939
+163
+21% +$167K 0.05% 77
2026
Q1
$714K Sell
776
-10
-1% -$10.1K 0.04% 79
2025
Q4
$845K Sell
786
-3
-0.4% -$2.87K 0.05% 69
2025
Q3
$602K Sell
789
-56
-7% -$41.7K 0.03% 78
2025
Q2
$659K Sell
845
-7
-0.8% -$5.44K 0.04% 70
2025
Q1
$704K Sell
852
-11
-1% -$9.15K 0.05% 69
2024
Q4
$666K Buy
863
+74
+9% +$61.3K 0.05% 80
2024
Q3
$699K Sell
789
-6
-0.8% -$5.39K 0.06% 61
2024
Q2
$720K Sell
795
-7
-0.9% -$5.6K 0.07% 62
2024
Q1
$624K Buy
802
+8
+1% +$5.69K 0.06% 63
2023
Q4
$463K Sell
794
-108
-12% -$63K 0.05% 70
2023
Q3
$484K Hold
902
0.06% 70
2023
Q2
$423K Sell
902
-4
-0.4% -$1.68K 0.05% 75
2023
Q1
$311K Sell
906
-4
-0.4% -$1.35K 0.04% 82
2022
Q4
$333K Sell
910
-19
-2% -$6.74K 0.05% 81
2022
Q3
$300K Buy
929
+4
+0.4% +$1.27K 0.05% 82
2022
Q2
$300K Sell
925
-17
-2% -$5.1K 0.05% 79
2022
Q1
$270K Hold
942
0.04% 87
2021
Q4
$260K Sell
942
-6
-0.6% -$1.52K 0.04% 88
2021
Q3
$219K Buy
948
+6
+0.6% +$1.48K 0.03% 82
2021
Q2
$216K Buy
+942
New +$189K 0.03% 83

Other funds holding LLY

Greenwood Gearhart's LLY Position: Q2 2026 in Review

Greenwood Gearhart increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $167K and bringing the position to 939 shares worth $1.13M. The position accounts for 0.05% of the portfolio, ranked #77.

Greenwood Gearhart first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Greenwood Gearhart held 939 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Greenwood Gearhart bought 163 Eli Lilly shares in Q2 2026, an estimated $167K.
  • Eli Lilly made up 0.05% of Greenwood Gearhart's portfolio in Q2 2026, its #77 holding.
  • Greenwood Gearhart first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greenwood Gearhart's 13F filing for Q2 2026, filed 24 Jul 2026.